Emerald Isle of Opportunity

File Photo A new association will be launched in New York City this month to unite Irish expatriates in the United States who are involved in life sciences. The aim of BioLink USA-Ireland, to be officially launched Oct. 9, is to help people reconnect with their home country and help develop the Irish biotech industry. Enterprise Ireland (EI), the trade and technology board of the Irish government, is setting up the project. Over the past year, EI established contacts with 400 people involved

Written byMartina Habeck
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

A new association will be launched in New York City this month to unite Irish expatriates in the United States who are involved in life sciences. The aim of BioLink USA-Ireland, to be officially launched Oct. 9, is to help people reconnect with their home country and help develop the Irish biotech industry.

Enterprise Ireland (EI), the trade and technology board of the Irish government, is setting up the project. Over the past year, EI established contacts with 400 people involved in the life sciences, including researchers, intellectual property and regulatory affairs specialists, and venture capital investors. The association is designed to inform expatriates about the life sciences in Ireland and to encourage members to contribute their experience, contacts, and expertise to biotechnology projects in their home country.

Association membership will be beneficial to people who want to return, and according to Deirdre McDonnell-Lee at EI, this holds true for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies